Cite
HARVARD Citation
Galeazzi, M. et al. (2014). SAT0232 A Phase IB Clinical Trial in Rheumatoid Arthritis of Dekavil (F8-IL10), A Novel Anti-Inflammatory Immunocytokine. Annals of the rheumatic diseases. pp. 675-676. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Galeazzi, M. et al. (2014). SAT0232 A Phase IB Clinical Trial in Rheumatoid Arthritis of Dekavil (F8-IL10), A Novel Anti-Inflammatory Immunocytokine. Annals of the rheumatic diseases. pp. 675-676. [Online].